Taotao Ma
- Molecular Biology top 5%
- Cancer Research top 2%
- Epidemiology top 5%
- Immunology top 10%
- Hepatology top 2%
- Topics
- Liver physiology and pathology (17 papers)Liver Disease Diagnosis and Treatment (15 papers)MicroRNA in disease regulation (8 papers)
- Cited by
- NephrologyCancer ResearchHepatology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Taotao Ma
77 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.6k
- Cancer Research 691
- Epidemiology 507
- Immunology 400
- Hepatology 351
Countries citing papers authored by Taotao Ma
This map shows the geographic impact of Taotao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taotao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taotao Ma more than expected).
Fields of papers citing papers by Taotao Ma
This network shows the impact of papers produced by Taotao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taotao Ma. The network helps show where Taotao Ma may publish in the future.
Co-authorship network of co-authors of Taotao Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Taotao Ma. A scholar is included among the top collaborators of Taotao Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taotao Ma. Taotao Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 20 | |
| 4 | 17 | |
| 5 | 22 | |
| 6 | 1 | |
| 7 | 20 | |
| 8 | 26 | |
| 9 | 67 | |
| 10 | 50 | |
| 11 | 20 | |
| 12 | 15 | |
| 13 | 43 | |
| 14 | 90 | |
| 15 | 36 | |
| 16 | 48 | |
| 17 | 69 | |
| 18 | 20 | |
| 19 | PI3K/Akt signaling pathway and liver fibrosis | 4 |
| 20 | 75 |
About Taotao Ma
Taotao Ma is a scholar working on Hepatology, Nephrology and Pharmacology, having authored 79 papers that have together received 2.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (17 papers), Liver Disease Diagnosis and Treatment (15 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Nephrology (332 citations), Cancer Research (691 citations) and Hepatology (351 citations). Taotao Ma has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiao‐Ming Meng, Cheng Huang, Jun Li, Cheng Zhi Huang, Xiongwen Lv, Yong He, Cheng Huang, Erbao Bian, Zhaolin Chen and Tingting Hu. Their work appears in journals such as PLoS ONE, Scientific Reports and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.